GL1X · GenesisL1 explorer

MolNFT v1 · #160674 · protein

S. aureus dihydrofolate reductase co-crystallized with 1-ethylpropyl- dihydropthalazine inhibitor and NADP(H)

6PR9: “S. aureus dihydrofolate reductase co-crystallized with 1-ethylpropyl- dihydropthalazine inhibitor and NADP(H)”. X-ray diffraction, 2 ligands (NAP, OWV), 1 pocket (best druggability 0.69). MolNFT v1 #160674 on GenesisL1: 3D…

PDB
6PR9
Type
protein
Length
162 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P0A017
Ligands
NAP, OWV
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 19% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydrofolate reductase (EC 1.5.1.3)protein16219% helix, 36% strandP0A017

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • OWV · (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(pentan-3-yl)-3,4-dihydrophthalazin-2(1H)-yl]prop-2-en-1-one · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13340.690.8238NAP, OWV

Compared structures

  • 6PR9 · S. aureus dihydrofolate reductase co-crystallized with 1-ethylpropyl-dihydropthalazine… · the same entry in another collection · chain A against A, TM-score 1.00
  • P0A017 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P0A017) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.